PROTAC degrader inhibitor, PROTAC ER Degrader-3, Purity ≥98%

Synonym: 2158322-29-1; AKOS040743822; Tert-butyl N-[(2S)-1-[[(3S,4S)-7-cyano-5-[4-[2-[2-[2-[2-[4-[(E)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]-2-oxoethoxy]ethoxy]ethylcarbamoyl]benzoyl]-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate; PROTAC degrader inhibitor

CAS Number: 2158322-29-1
Compound CID: 166594991

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

PROTAC ER Degrader-3 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of PROTAC degrader. The molecular weight of the compound is 1220.41, and its molecular formula is C₇₁H₇₇N₇O₁₂.

Molecular Weight

1220.41

Molecular Formula

C₇₁H₇₇N₇O₁₂

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

PROTAC ER Degrader-3 can be used for its potential use in estrogen receptor-positive breast cancer, especially in cases where tumors have become resistant to standard endocrine therapies.